Literature DB >> 77276

The capping of lymphocytes and other cells, studied by an improved method for immunofluorescence staining of frozen sections.

L Y Bourguignon, K T Tokuyasu, S J Singer.   

Abstract

Experiments have been carried out on the capping by lectins and antibodies of surface receptors of mouse splenic T and B lymphocytes and other cells, in which the surface distribution of the lectin or antibody, and the intracellular distribution of myosin or actin, were determined on the same cells by a double fluorescence technique. For this purpose, a general method for intracellular staining was developed which is intended to preserve sensitive antigens and fragile ultrastructural elements. The method involves mild formaldehyde fixation of the cells or tissues, infusion with concentrated sucrose, rapid freezing, and the preparation of frozen sections thinner than 1 micrometer thickness. The immunofluorescent or other appropriate fluorescent reagents are then applied to the thawed section. In the present experiments, intracellular actin was detected using a fluorescent staining method based on the interaction of F-actin with heavy meromyosin, while intracellular myosin was detected by an indirect immunofluorescence procedure. Our findings were that the formation of a cap by each of the lectins or antibody reagents was always accompanied by a concentration of myosin and actin directly under the cap. These and other results suggest that capping is an active process in which actin and myosin participate directly in the formation of all caps. This proposal carries important new implications for the molecular mechanism of capping.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77276     DOI: 10.1002/jcp.1040950302

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Fluorescent staining of the actin cytoskeleton in human lymphocytes, monocytes and polymorphonuclear cells using a DNAse 1/anti-DNAse 1 immunoglobulin fluorescein conjugated system.

Authors:  P J Philip; I Sudaka; B Mely-Goubert
Journal:  Histochemistry       Date:  1992

2.  Stimulation of lymphocyte receptor capping by the ionophore monensin.

Authors:  L Y Bourguignon; B C Pressman
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

3.  Receptor capping in mouse T-lymphoma cells: a Ca2+ and calmodulin-stimulated ATP-dependent process.

Authors:  L Y Bourguignon; W G Kerrick
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

4.  Immunochemistry on ultrathin frozen sections.

Authors:  K T Tokuyasu
Journal:  Histochem J       Date:  1980-07

5.  Capping of concanavalin A receptors and their association with microfilaments in monolayer grown human fibroblastoid cells.

Authors:  L Y Bourguignon; R J Rozek
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

6.  Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists.

Authors:  G R Nemerow; N R Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Regulation of receptor capping in mouse lymphoma T cells by Ca2+-activated myosin light chain kinase.

Authors:  W G Kerrick; L Y Bourguignon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Effects of free fatty acids on the organization of cytoskeletal elements in lymphocytes.

Authors:  R L Hoover; K Fujiwara; R D Klausner; D K Bhalla; R Tucker; M J Karnovsky
Journal:  Mol Cell Biol       Date:  1981-10       Impact factor: 4.272

9.  Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin.

Authors:  S Kellie; B Patel; E J Pierce; D R Critchley
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

10.  Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex.

Authors:  L Y Bourguignon; M L Nagpal; K Balazovich; V Guerriero; A R Means
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.